INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
107 hedge funds and large institutions have $152M invested in Infinity Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
107
Holders Change
+10
Holders Change %
+10.31%
% of All Funds
1.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
29
Reduced
29
Closed
14
Calls
$5.11M
Puts
$1.66M
Net Calls
+$3.45M
Net Calls Change
+$2.72M
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$7.25M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$5.67M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.02M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$1.89M |
| 5 |
Two Sigma Advisers
New York
|
+$1.81M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$11.3M |
| 2 |
ACM
Altium Capital Management
New York
|
-$2.79M |
| 3 |
Renaissance Technologies
New York
|
-$2.29M |
| 4 |
JGC
J. Goldman & Co
New York
|
-$1.55M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.27M |
